Long-term Covid virus less likely to affect vaccination than unvaccinated people, new review of 15 studies from UKHSA (The British Health Safety Agency issued, with English translation) this Tuesday (15).
People who received two doses of the vaccine from Pfizer-BioNTech, AstraZeneca or Moderna, or one dose of the vaccine from J&J, were half as likely to develop persistent symptoms of covid-19 than those who were not vaccinated, the agency said. .
“These studies add to the potential benefits of receiving a full course of the Covid-19 vaccine,” said Mary Ramsay, UKHSA’s head of immunization. “Vaccination is the best way to protect yourself from severe symptoms when you get an infection, and it can also help reduce the long-term impact.”
British Prime Minister Boris Johnson has lifted restrictions to contain Covid-19 in England, with booster doses and lower severity of the Omicron variant weakening the link between cases and deaths from the virus.
However, the average number of cases in the UK remains around 50,000 per day, and mild cases of Covid-19 can still lead to the long-term debilitation of coronavirus and symptoms related to fatigue, memory problems and mental confusion.
The health agency said about 2% of Britain’s population reported long-term symptoms of Covid-19, the most common being fatigue, shortness of breath and muscle or joint pain.
Of the four studies that compared long-term coronavirus symptoms before and after vaccination, three show that more people reported improvement in permanent coronavirus symptoms rather than worsening after vaccination.
Three other studies concluded that prolonged symptoms of the disease improved in those who were vaccinated compared to those who remained unvaccinated.
